Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol)

BACKGROUND: Pelvic organ prolapse is a common health problem: the lifetime risk of undergoing surgery for pelvic organ prolapse by the age of 85 years is 19%. Pelvic organ prolapse has significant negative effects on a woman’s quality of life. Worldwide, vaginal hysterectomy is the leading treatment...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Womens Health
Autors principals: van IJsselmuiden, Mèlanie N, Coolen, Anne-Lotte WM, Detollenaere, Renée J, den Boon, Jan, Bongers, Marlies, van de Pol, Geerte, Vollebregt, Astrid, Radder, Celine M, Deprest, Jan, van Eijndhoven, Hugo WF
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254385/
https://ncbi.nlm.nih.gov/pubmed/25231240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6874-14-112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars